Asthmatech IVS
IVSDissolvedAdvertising protectionCVR 38559842Ikarosvej 18, 9210 Aalborg SØComputerprogrammering· NACE 620100Est. 2017 · 9 years old— employees
Loading company…
Overview
Asthmatech IVS is a Danish IVS based in Aalborg SØ, operating in the Computerprogrammering sector. Incorporated in 2017, the company reported revenue of DKK 0 in its latest annual filing.
Revenue 2020
0K DKK
EBITDA margin
—
Net profit 2020
0K DKK
-100% vs 2019
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
-584.4 %
Very weakAmong the 10% lowest rated companies in the industry
20172020
Liquidity ratioCurrent assets ÷ Short-term debt
0.1×
Very weakAmong the 20% lowest rated companies in the industry
20172020
Return on assets (ROA)Net profit ÷ Total assets × 100
0.0 %
AverageAround the average of companies in the same industry
20172020
EBITDA — year on year
DKK thousandsKey figures
Annual report 2020| Revenue | 0K DKK | — |
| EBITDA | 0K DKK | — |
| Net profit | 0K DKK | -100% |
| Total assets | 4.4K DKK | 0% |
| Equity | -25.6K DKK | 0% |
| Employees | — | — |
Company information
Legal name
Asthmatech IVS
CVR number
38559842
Legal form
Iværksætterselskab
NACE code
620100 · Computerprogrammering
Founded
8 April 2017 · 9 years
Share capital
DKK 20,000
Employees
—
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør og bestyrelsesformanden i forening
Contact
Address
Ikarosvej 18, 9210 Aalborg SØ
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2020), Asthmatech IVS reported revenue of DKK 0, a decrease of 100% on the year before. The figures on this page draw on 4 annual filings covering 2017 to 2020. The bottom line showed a break-even result.
At the end of 2020, current assets covered short-term debt 0.1 times.
Financials
Revenue
DKK thousandsEBITDA
DKK thousandsIncome statement
DKK thousands| Item | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|
| Revenue | 0 | 1 | -34 | -13 |
| Staff expenses | -0 | -0 | -0 | -0 |
| EBITDA | 0 | 1 | -34 | -13 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | 0 | 1 | -34 | -13 |
| Net financials | 0 | 0 | -0 | 0 |
| Profit before tax | 0 | 1 | -34 | -13 |
| Tax | -0 | -0 | -0 | -0 |
| Net profit | 0 | 1 | -34 | -13 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
DKK thousands| Item | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|
| Total assets | 4 | 4 | 21 | 41 |
| Equity | -26 | -26 | -27 | 7 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 30 | 30 | 48 | 34 |
| Total debt | 30 | 30 | 48 | 34 |
Financial ratios
5-year trendEBITDA margin
0.0 %
20172020
Equity ratio
-584.4 %
Very weakAmong the 10% lowest rated companies in the industry
20172020
Return on equity
—
20172020
Net profit margin
0.0 %
20172020
Asset turnover
0.00×
Very weakAmong the 10% lowest rated companies in the industry
20172020
Debt / equity
—
20172020
Sector performance
14 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Return on assets (ROA)Average
Around the average of companies in the same industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Basic earning power (BEP)Average
Around the average of companies in the same industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Gross marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Not rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on net assets (RONA)Not rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Capacity ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioVery weak
Among the 20% lowest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioVery weak
Among the 20% lowest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioVery weak
Among the 20% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioVery weak
Among the 10% lowest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioVery weak
Among the 10% lowest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Income to debtAverage
Around the average of companies in the same industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtAverage
Around the average of companies in the same industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest rate on debtVery strong
Among the 10% highest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginAverage
Around the average of companies in the same industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Debt to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Interest coverageNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The ability to pay the interest on the company's debt out of its earnings.
Efficiency & development
Asset turnoverVery weak
Among the 10% lowest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Equity to contributed capitalVery weak
Among the 20% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in debtAverage
Around the average of companies in the same industry
The size of this year's increase or decrease in the company's debt.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
One-year change in equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The size of this year's increase or decrease in the company's equity.
Annual reports & filings
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-04-08 – 2017-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|
Former (2)
AS Chief Executive Officer | Chief Executive Officer | 2017 – 2021 |
JH Chief Executive Officer | Chief Executive Officer | 2017 – 2017 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|
Former (1)
JH Chairman | Chairman | 2017 – 2021 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Individual | 100% | 100% | 2021 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2017 | |
| Company | 100% | 100% | 2021 | |
| Individual | 33.33–49.99% | 33.33–49.99% | 2017 | |
| Individual | 25–33.32% | 25–33.32% | 2017 | |
| Company | 25–33.32% | 25–33.32% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
JH HOLDING 010112 ApS
Asthmatech IVS (this company)Board network connections
Board members of Asthmatech IVS also hold positions in 13 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørgen Hansen | Chief Executive Officer | 8 companiesMany roles |
| Adam Søholm Hansen | Chief Executive Officer | 5 companies |
Frequently asked questions
What is the CVR number of Asthmatech IVS?
Asthmatech IVS is registered with CVR / Virk under CVR 38559842.
Where is Asthmatech IVS headquartered?
Asthmatech IVS's registered address is Ikarosvej 18.